Sphingoid bases and not ceramide or phosphosphingoid bases are required for CHA1 up-regulation. CHA1 was induced by serine in key mutant strains deleted in key sphingolipid enzymes and after treatment with pharmacological inhibitors in the JK9-3dα background. A, wild-type and mutant strains were grown to mid-log in SC −Thr and induced with 0.5 mm serine for 15 min, and expression was measured by qRT-PCR. B and C, for fumonisin and aureobasidin treatment, cells were pretreated for 2 h with drug or vehicle (0.02% methanol) before induction. B, cells were not induced (filled diamond) or induced with serine after treatment with 0, 0.2, 0.5, and 1.0 mm fumonisin (open triangles), or 0, 0.5, 1, 2, and 3 μm aureobasidin (C) (open squares); expression with no induction is shown (filled circle). Induction by serine was found to be significant at p < 0.01 by one-way ANOVA in all samples. CHA1 expression was not significantly different in any of the mutant strains after induction at p < 0.05 confidence determined by two-way ANOVA. Neither pharmacological inhibitor showed significant inhibition of induction at p < 0.05 confidence by one-way ANOVA. Data presented are the average ± S.E. (error bars) of at least triplicate experiments. D, sphingolipid metabolic pathway illustrates the key points where the pathway was disrupted in this study using inhibitors or mutant strains indicated in bold font.